Aequs Limited Approves Grant of 350,000 Employee Stock Options
Aequs Limited approved granting 350,000 Employee Stock Options (ESOPs) under ESOP 2025. The grant is effective August 31, 2026, with an exercise price of ₹246.00 per option. This action is compliant with SEBI regulations and will result in 350,000 equity shares upon exercise.
The grant of employee stock options is a routine event and typically has a limited immediate impact on the company's stock price or financial performance, as it is a long-term incentive plan.
The announcement pertains to the routine grant of employee stock options, which is a standard corporate practice and does not inherently indicate a positive or negative development for the company's financials or operations.
Aequs Limited (formerly Aequs Private Limited) has announced that its Nomination and Remuneration Committee (NRC) has approved the grant of 350,000 Employee Stock Options (ESOPs) under the Aequs Employee Stock Option Plan 2025. The approval was given at a meeting held on August 29, 2026, with the grant effective on August 31, 2026.
Each stock option grants the holder the right to acquire one equity share of face value ₹10. The exercise price for these options is set at ₹246.00 per stock option, which is based on the last traded price of the company's equity shares on the National Stock Exchange of India Limited as of August 28, 2026. The ESOPs are in compliance with SEBI (Share Based Employee Benefits and Vesting) Regulations, 2021.
These granted stock options will have a vesting period of a minimum of one year from the date of grant, with vesting schedules specified in individual grant letters. Once vested, the options can be exercised within three years from the respective vesting date upon payment of the exercise price and applicable taxes. A total of 350,000 equity shares will arise if all granted options are vested and exercised.
A plain-language summary of a public exchange filing by Aequs Limited. Read the original for the full detail.